Skip to content Research
- A Bacoside containing Bacopa monnieri extract reduces both morphine hyperactivity plus the elevated striatal dopamine and serotonin turnover Rauf et al. (2012)
- Bacopa monnieri: A promising herbal approach for neurodegenerative disease treatment supported by in silico and in vitro research Ali et al. (2023)
- In vitro cultures of Bacopa monnieri and an analysis of selected groups of biologically active metabolites in their biomass Muszyńska et al. (2016)
- Role of Herbal Medicines in the Management of Brain Injury Safdari et al. (2021)
- The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial Lopresti et al. (2025)
- A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study Majeed et al. (2023)
- A Standardized Withania somnifera (Linn.) Root Extract with Piperine Alleviates the Symptoms of Anxiety and Depression by Increasing Serotonin Levels: A Double-Blind, Randomized, Placebo-Controlled Study Majeed et al. (2024)
- Ashwagandha Root Extract Mitigates Fibromyalgia-like Symptoms via Neurochemical and Histological Modulation in Mice Hasanyn et al. (2025)
- Hydroalcoholic Extract of Ashwagandha Improves Sleep by Modulating GABA/Histamine Receptors and EEG Slow-Wave Pattern in In Vitro - In Vivo Experimental Models Murthy et al. (2022)
- Interventions for generalized anxiety disorder Byrne (2023)
- A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters Robertson et al. (2009)
- Adolescent stress differentially modifies dopamine and norepinephrine release in the medial prefrontal cortex of adult rats Carboni et al. (2024)
- Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine Kuczenski et al. (1997)
- Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine Parada et al. (1988)
- Norepinephrine and stimulant addiction Sofuoglu et al. (2009)
- Choline supplements: An update Kansakar et al. (2023)
- Effect of a new cognition enhancer, alpha-glycerylphosphorylcholine, on scopolamine-induced amnesia and brain acetylcholine Lopez et al. (1991)
- L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders Putri et al. (2026)
- Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment Lee et al. (2017)
- Production of α-Glycerylphosphorylcholine in Fermented Roots, Tubers, and Fruits Tse et al. (2024)
- Addiction Lingford-Hughes et al. (2003)
- Alcohol withdrawal seizures Hughes (2009)
- Endogenous opiates: 1985 Olson et al. (1986)
- GABA(B) Receptors and Alcohol Use Disorders: Preclinical Studies Holtyn et al. (2022)
- Opioids and alcoholism Oswald et al. (2004)
- Diagnosis and Management of Resistant Hypertension: A Review Azizi et al. (2026)
- Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial Blumenthal et al. (2021)
- Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease Sacheli et al. (2019)
- Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review Safarpour et al. (2023)
- Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 Dellinger et al. (2013)
- Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 Dellinger et al. (2013)
- The Origin and Clinical Relevance of Yoga Nidra Pandi-Perumal et al. (2022)
- Vasopressor and Inotrope Therapy in Cardiac Critical Care Jentzer et al. (2021)
- Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease Church (2021)
- Acetyl-L-carnitine and Alzheimer's disease: pharmacological considerations beyond the cholinergic sphere Carta et al. (1993)